Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403. (Q37536057)

20 August 2017

1 reference

title

Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403. (English)

1 reference

20 August 2017

Hong C Shen

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Therapeutic Patents

20 August 2017

published in

1 reference

20 August 2017

volume

19

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

1149-1155

1 reference

One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Drug treatment of lipid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Molecular identification of high and low affinity receptors for nicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Nicotinic acid receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Molecular modeling aided design of nicotinic acid receptor GPR109A agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

Tetrahydro anthranilic acid as a surrogate for anthranilic acid: application to the discovery of potent niacin receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902798061

10.1517/13543770902798061

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference